Non Alcoholic Fatty Liver Disease Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
BLTE | B | Belite Bio, Inc. | -0.09 | |
ALGS | B | Aligos Therapeutics, Inc. | -2.53 | |
AKRO | C | Akero Therapeutics, Inc. | 0.90 | |
GALT | C | Galectin Therapeutics Inc. | -0.18 | |
IVA | C | Inventiva S.A. | -8.39 | |
SGMT | D | Sagimet Biosciences Inc. | 2.46 | |
PLRX | D | Pliant Therapeutics, Inc. | 2.99 | |
ETNB | D | 89bio, Inc. | 7.02 | |
GYRE | D | Gyre Therapeutics, Inc. | -4.96 | |
GNFT | F | GENFIT S.A. | -1.62 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Health Information Services
Related Stock Lists:
Hepatitis
Steatohepatitis
Alcohol
Liver Disease
Medicine
Biopharmaceutical
Fibrosis
Liver Fibrosis
Cancer
Clinical Medicine
Drug Development
Hepatology
Idiopathic Pulmonary Fibrosis
Metabolic Disease
Orphan Drug
Pulmonary Fibrosis
Acne
Antiviral Therapies
Autoimmune Disease
Biology
Related ETFs - A few ETFs which own one or more of the above listed Non Alcoholic Fatty Liver Disease stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SURI | C | Simplify Exchange Traded Funds Simplify Propel Opportunities ETF | 6.84 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 4.06 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 2.42 | |
HRTS | D | Tema Cardiovascular and Metabolic ETF | 1.28 | |
MEDX | F | Horizon Kinetics Medical ETF | 0.89 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
Health Information Services
Related Stock Lists:
Hepatitis
Steatohepatitis
Alcohol
Liver Disease
Medicine
Biopharmaceutical
Fibrosis
Liver Fibrosis
Cancer
Clinical Medicine
Drug Development
Hepatology
Idiopathic Pulmonary Fibrosis
Metabolic Disease
Orphan Drug
Pulmonary Fibrosis
Acne
Antiviral Therapies
Autoimmune Disease
Biology
- Non Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in the liver, causing inflammation and damage. It is the most common form of liver disease in the United States, affecting up to 25% of the population. NAFLD is closely linked to obesity, diabetes, and high cholesterol, and can lead to serious complications such as cirrhosis and liver cancer. Treatment typically involves lifestyle changes such as weight loss, exercise, and a healthy diet.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles